Global Electrophysiology (EP) Devices Market Research Report Forecast: (2025-2030)

Market Insights & Analysis: Global Electrophysiology (EP) Devices Market (2025-30):

The Global Electrophysiology (EP) Devices Market size was valued at around USD 12 Billion in 2024 and is projected to reach USD 24 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e. 2025-30. This growth is attributed to increasing cardiovascular diseases such as cardiac arrhythmias resulting from changes in the lifestyle of humans globally coupled with increased alcohol and tobacco consumption and unhealthy food intake. Additionally, with the rising elderly population, heart-related diseases around the world are drastically elevating and there is a decrease in fertility rate too. As per the World Bank, the fertility rate was at 2.26 in 2022, resulting in an increase in the number of elderly humans around the world.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

In addition, stroke cases are increasing worldwide. According to the review of the WHO, from 1990 and 2019, the number of cases of stroke in the world has escalated to 70%, stroke deaths have increased to 43%, and also doubled cases to the prevalence of stroke during the same period. The cases of strokes and the increasing prevalence will cause a rise in the demand for electrophysiology devices worldwide.

The pandemic has boosted the expenditure for global healthcare spending. Nations in the world have been investing to strengthen their health capabilities, and hence, the number of healthcare facilities is also going up. For instance, North America, which holds the top position in the Global Electrophysiology (EP) Devices Market, has experienced an increase in its healthcare spending. The USA is the main market in that region, whose spending is reported to be at around USD 4.1 trillion in the year 2020, and this has increased consecutively since then. Such developments in scenarios will support the growth of the market throughout the forecast period.

Global Electrophysiology (EP) Devices Market Driver:

Rising Cases of Cardiovascular Diseases (CVD) – Globally, the majority of deaths are caused by chronic diseases. CVD is at the top of them, as these collectively account for more than 30% of all deaths worldwide. The WHO has said that the deaths attributed to CVD have moved up from approximately 12.1 million in 1990 to around 70% and have reached 20.5 million in 2021, reveals the World Heart Foundation. This is primarily because the population is on the rise worldwide. The reduced birth rate around the world, which means a growing older population, will push the incidence of CVD up further.

The rising number of cases of CVD will propel the growth of medication and rehabilitation that comes along with it. However, optimal usage of drugs, timely check-ups, and monitoring for CVD are of utmost importance for its effective treatment. Thus this shall boost demand for electrophysiology devices in the market.

Global Electrophysiology (EP) Devices Market Opportunity:

Growing Cases of Arrhythmia – Arrhythmia refers to an abnormal heartbeat pattern resulting in either faster or slower than normal. Atrial Fibrillation (AF) commonly affects cases among all worldwide. The increase in awareness of AF and extensive tracking has resulted in an increase in the count of cases. As per a study conducted by the Global Burden of Disease Project conducted in 2016, the number of Atrial Fibrillation patients worldwide was around 46.3 million and is increasing steadily. Additionally, as per a study in American Heart Association Journals, AF cases in the U.S. are expected to reach 16 million by 2050 with 72 million in Asia for the same period. The reason attributed to the rise is the sedentary lifestyle resulting from unhealthy consumption coupled with the increasing elderly population. Thus cases of Arrhythmia are leading to the growth in the demand for electrophysiology devices worldwide.

Global Electrophysiology (EP) Devices Market Challenge:

Regulatory Approvals and Standards – Globally, the healthcare industry is highly regulated by the government to ensure the quality, safe, and effective treatment of patients without endangering their lives. The dynamics result in market players getting the necessary regulatory approvals before introducing any products in the market. These developments raise the entry barriers to the players entering the market. Apart from this, any failure or malfunction in the devices results in immediate recalls by the country due to the adherence to strict regulatory standards. For instance, Abbott Laboratories got a “class I recall” for implantable pulse generators (IPGs) due to their connectivity flaw, which made them unusable.

This resulted in the company recalling over 155,000 IPGs in 2023. Similarly, in December 2024, Boston Scientific Corporation issued an alert to patients regarding the replacement of its pacemakers following the death of two patients due to the failure of its pacemakers. This resulted in the company recalling around 203,000 of the impacted devices. These dynamics heavily impact market participation, thereby restraining market growth.

Global Electrophysiology (EP) Devices Market (2025-30): Segmentation Analysis

The Global Electrophysiology (EP) Devices Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Device Type:

• Electrophysiology Ablation Catheters
  • Cryoablation Electrophysiology Catheters
  • Radiofrequency Ablation Catheters
  • Laser Ablation Systems
  • Microwave Ablation Systems
  • Navigational Advanced Mapping Accessories
• Electrophysiology Diagnostic Catheters
  • Conventional Electrophysiology Diagnostic Catheters
  • Advanced Electrophysiology Diagnostic Catheters
  • Ultrasound Electrophysiology Diagnostic Catheters
• Electrophysiology Laboratory Devices
• Access Devices
• Others

In 2024, the electrophysiology ablation catheters hold more than 43% of the share in the Global Electrophysiology (EP) Devices Market. This growth is attributed to the rising heart-related conditions such as cardiac Arrhythmias coupled with the demand for advanced minimally invasive treatment techniques for their treatment. The technique offers reliable solutions, where a catheter threads around the heart and uses different technologies (like radiofrequency, etc.) to destroy the source tissues responsible for irregular signals in the rhythm of the heart. Moreover, many leading players in the market are increasingly expanding this device type worldwide. For instance,

• In October 2024, Abbott Laboratories reported that the company has achieved significant milestones towards the development of its two pulse field ablation devices. This outcome is a big step towards advancing the treatment of patients with conditions like Atrial Fibrillation.
• In January 2024, Biosense Webster got approval from Japan’s Ministry of Health Labour and Welfare (MHLW) for its “Varipulse,” a pulse field ablation device.

Other market players, such as Boston Scientific Corporation and Medtronic, have similarly secured regulatory approvals for their ablation catheter products in various regions worldwide. The rising cases of cardiac arrhythmias due to the rising elderly population will boost the demand for ablation catheters, thereby driving market growth globally.

Based on Modality:

• Implantable
• External

The implantable segment accounts for over 50% share in the Global Electrophysiology (EP) Devices Market in 2024. This is primarily due to increasing cases of cardiovascular diseases across the globe, fueling the adoption of implantable electrophysiology devices. Implantable EP devices—the defibrillators and pacemakers—record the heart for any anomaly in the heartbeat; this can actually prevent or even reduce the occurrence of strokes. Moreover, these devices allow for more efficient therapy and diagnosis for bradycardia, heart failure, arrhythmia, etc. This makes these devices highly popular among healthcare providers worldwide.

Additionally, with technological advancements, these devices have become small in size, and they are also capable of remote monitoring through a wireless connection. This is very convenient for patients and doctors to comfortably monitor or follow the health of a patient's heart. These market dynamics permit the implanted devices to lead the market over the forecasted period.

Global Electrophysiology (EP) Devices Market (2025-30): Regional Projections

Geographically, the Global Electrophysiology (EP) Devices Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

North America is the leading region of the Global Electrophysiology (EP) Devices Market and holds more than 45% of the shares in 2024. The main reason behind this market scenario is the presence of the USA within that region. This nation is spending heavily on its healthcare. Its healthcare expenditure for 2023 will be around USD 4.8 trillion. The USA also hosts a huge number of patients with heart diseases. The US Centers for Disease Control and Prevention state that heat diseases are the leading cause of death in the USA, accounting for nearly 20% of total deaths in the country.

According to the CDC, 702,880 people died from heart disease in the USA in 2022, and around 805,000 Americans suffer from heart attacks every year. As the fertility rate of the countries in the region is going down, along with an increase in the number of the country's elderly population, the heart patients in the region will be increasing further, which will consequently drive the growth in the demand for electrophysiology devices in the region.

Global Electrophysiology (EP) Devices Industry Recent Development:

• November 2024: Boston Scientific Corporation is in its M&A process with the Cortex, which possesses the diagnostic mapping technology to detect atrial fibrillation (AFib) outside the pulmonary veins.
• September 2024: Abbott has announced that it has partnered with iCardio.ai to develop an AI application for its Electrophysiology Imaging technology.

Gain a Competitive Edge with Our Global Electrophysiology (EP) Devices Market Report

1. Global Electrophysiology (EP) Devices Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Electrophysiology (EP) Devices Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.